• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

Malaysia’s Top Glove posts 48% profit drop, to seek Hong Kong listing

September 17, 2021 by David Barret Leave a Comment

September 17, 2021

By Liz Lee and Scott Murdoch

KUALA LUMPUR (Reuters) -Malaysia’s Top Glove Corp Bhd said on Friday it will renew its listing application to push ahead with its plans to raise $1 billion in Hong Kong despite a 48% slide in its quarterly earnings.

The world’s largest medical glove maker has been seeking a dual primary listing on the Hong Kong Stock Exchange since last year, but the deal was put on hold after it was slapped with an import ban from U.S. authorities. It already has a primary listing in Malaysia and a secondary listing in Singapore.

The year-long ban was imposed on Top Glove for alleged forced labour abuses and was lifted last week https://ift.tt/3hGkmx7. It stalled the company’s listing https://ift.tt/3Al5nQr plans and hurt sales, particularly to the United States, which normally accounts for 15% of the group’s total sales.

The ban has hit Top Glove’s reputation just as it was making record profits on increased demand for its gloves during the COVID-19 pandemic.

Last year, Citigroup Inc and UBS Group AG opted not to sponsor the deal on concerns of reputational risk. China International Capital Corp is currently the sole sponsor of the deal.

A source with direct knowledge of the matter said the ban removal was important and the deal would now be able to be marketed more broadly for a wider set of investors.

The source could not be identified as the information had not been made public.

Top Glove is aiming to raise $1 billion in the Hong Kong listing and will likely appoint more bankers in the future, the source said, adding it was set on completing the IPO as soon as possible.

Top Glove did not address questions about the listing during a briefing on the quarterly results, which showed a 48% drop in the company’s fourth-quarter earnings.

“(The) results were softer on the back of normalising demand following (a) mass vaccine rollout, leading to lower sales volume and (prices), which were not matched by a corresponding reduction in raw material prices,” the manufacturer said in a statement.

It recorded a net profit of 607.9 million ringgit ($145.88 million) during June-August, compared with 1.17 billion ringgit a year ago, lagging behind the 8.69 billion ringgit estimate by analysts in a Refinitiv poll.

Revenue slumped 32% to 2.11 billion ringgit, a stock exchange filing showed.

Sales to the United States fell to 4% of group sales in the quarter but were seen “fully normalising” after the ban lift, the company said.

($1 = 4.1670 ringgit)

(Reporting by Liz Lee in Kuala Lumpur and Scott Murdoch in Hong Kong; Editing by Sherry Jacob-Phillips and Ana Nicolaci da Costa)

Source Link Malaysia’s Top Glove posts 48% profit drop, to seek Hong Kong listing

David Barret
David Barret

Related posts:

  1. Tennis-Auger-Aliassime breaks down Tiafoe’s defences to reach quarters
  2. Qualcomm says it will supply chip for new Renault electric vehicle
  3. China’s Liu He says support for private business has not changed
  4. Standard Chartered arranges $1.1 billion financing for Angola water project

Filed Under: News

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

  • What Is The Purpose Of Those Lines On Your Towels?
  • The Invisible World Around Us: How Can We Capture And Clean The Air We Breathe?
  • 85-Million-Year-Old Dinosaur Eggs Dated Using “Atomic Clock For Fossils” For The First Time
  • Why Shouldn’t You Kiss Babies? New Study Shows Even Healthy Newborns Can Become Severely Ill With RSV
  • Earth Has A New Quasi-Moon – And It Has Probably Been Around For Decades
  • Want To Kill Your Prey? Do It Feather-Legged Lace Weaver Spider Style And Vomit All Over Them
  • IFLScience The Big Questions: Are We In The Anthropocene?
  • The Wildfire Paradox Affecting 440 Million People Has As Worrying A Solution As You’d Expect
  • AI May Infringe On Your Rights And Insult Your Dignity (Unless We Do Something Soon)
  • How Do You Study Cryptic Species? We’re Finally Lifting The Lid On The World’s Least Understood Mammals
  • Once-In-A-Decade Close Encounter With Hazardous Asteroid 2025 FA22 Approaches
  • With 229 Pairs, This Beautiful Animal Has The Highest Number Of Chromosomes Of Any Animal
  • “An Unimaginable Breakthrough”: Loudest-Ever Gravitational Wave Collision Proves Stephen Hawking Correct
  • Exciting Martian Mudstone Has Features That Might Be Considered Biosignatures
  • How Long Did Dinosaurs Live? “It’s A Big Surprise To People That Work On Them”
  • NASA’s Mysterious Announcement: “Clearest Sign Of Life That We’ve Ever Found On Mars”
  • New Brain Implant Can Decode Your Internal Monologue, Raising Fears Of Mind Reading
  • “Immediate, Sustained, And Devastating” Pain: The Most Venomous Mammal Packs An Extremely Nasty Sting
  • Domestic Cats Keeping Making Hybrids. That’s A Problem, And Yes – That Includes Some Pets
  • These Strange Little Lizards Have Toxic Green Blood, And No One Knows Exactly Why
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version